EOLS Evolus, Inc. Common Stock
$7.37▲ +2.79%
Healthcare
Other
Pre-market
$7.40▲ +0.41%
Oct 28, 4:53 AM ET
Volume 601.0K
Avg Volume (10D) 680.0K
Key Metrics & Fundamentals
Market Cap
$486.79M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.86 - 9.31
% vs 50 MA
-8.22%
% vs 200 MA
18.28%
RSI-14
46.3
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.15
Free Cash Flow
-$4.09M
Gross Rev
$84.08M
Gross Profit
$57.18M
EBITDA
-$1.34M
COGS
$26.90M
Operating Exp
$60.47M
Operating Income
-$3.29M
EBIT
-$3.29M
Pretax Income
-$8.21M
Net Income
-$8.05M
EPS (Diluted)
-0.12
Price & Volume History
Loading chart…
Recent News
Evolus to Report Third Quarter Financial Results on November 4, 2026
Business Wire · Oct 21, 2026 8:30 AM ET
Evolus Signs Option Agreement With Company Developing Injectable Treatment for Hair Restoration
MT Newswires · Oct 14, 2026 10:15 AM ET
Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program
Business Wire · Oct 14, 2026 8:30 AM ET
UTMD Trades at a Premium to the Industry: How to Play the Stock?
Zacks · Oct 8, 2026 1:02 PM ET
FDA Flags Evolus’ Jeuveau Instagram Promotion As Misleading, Seeks Corrective Action
Stocktwits · Oct 2, 2026 1:41 PM ET
Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes
Business Wire · Oct 1, 2026 8:30 AM ET
Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future
Insider Monkey · Sep 9, 2026 2:10 AM ET
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
CNW Group · Sep 1, 2026 11:37 AM ET
Telix Appoints David Gill as Chair
GlobeNewswire · Aug 31, 2026 6:21 PM ET
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet
Zacks · Aug 27, 2026 9:55 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See EOLS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.